Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00117286

Public ClinicalTrials.gov record NCT00117286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Patients With Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was an extension study for the study FE200486 CS14 (NCT00116779). Each participant was to be treated until he was discontinued or withdrawn from the study, or a marketing authorization for degarelix had been obtained. The study was terminated when all ongoing participants had been treated for at least 5 years.

Study identification

NCT ID
NCT00117286
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
57 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
Aug 31, 2009
Completion
Oct 31, 2009
Last update posted
Dec 17, 2025

2005 – 2009

United States locations

U.S. sites
17
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209
Advanced Urology Medical Center Anaheim California 92801
West Coast Clinical Research Tarzana California 91356
Western Clinical Research Torrance California 90505
Urology Associate PC' Denver Colorado 80210
South Florida Medical Research Aventura Florida 33180
SW Florida Urological Associates Fort Myers Florida 33907
Northeast Indiana Research, LLC Fort Wayne Indiana 46825
Regional Urology Shreveport Louisiana 71106
Lawrenceville Urology Lawrenceville New Jersey 08648
The Urology Center Greensboro North Carolina 27401
State College Urologic Association State College Pennsylvania 16801
University Urological Research Institute Providence Rhode Island 02904
Urology San Antonio Research San Antonio Texas 78229
University of Vermont, Dept of Surgery South Burlington Vermont 05403
Virginia Urology Center Richmond Virginia 23235
Investigational site Seattle Washington 98166

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00117286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00117286 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →